Dr. Xin Dong | Medicine and Health Sciences | Research Excellence Award
Affiliated Hangzhou First People’s Hospital, Westlake University | China
Dr. Xin Dong is a leading researcher in hepatobiliary and pancreatic diseases, with a strong focus on translational and clinical research. His work integrates advanced computational methods, including deep learning, with clinical oncology to improve early detection and treatment outcomes, particularly in liver and pancreatic cancers. He has contributed significantly to understanding tumor biomarkers, cancer-associated metabolic disorders, and immunotherapy strategies. His scholarly output includes impactful publications in high-quality journals, reflecting contributions to cancer diagnostics, prognosis modeling, and minimally invasive therapeutic approaches. His research advances precision medicine and supports improved survival outcomes in complex gastrointestinal malignancies.
Featured Publications
A case of pancreatic cancer treated with chemotherapy combined with immunotherapy and targeted therapy
– Journal of Zhejiang University (Medical Sciences), 2023
Prediction of risk and overall survival of pancreatic cancer from blood soluble immune checkpoint-related proteins
– Frontiers in Immunology, 2023